4-nitroquinoline 1-oxide
4-nitroquinoline 1-oxide has been studied in 1 paper since 2018: none in people yet, 1 in cells. No study of it in people or animals has been published yet. The newest paper, Apr 26, 2018: “Low doses of DNA damaging agents extend Saccharomyces cerevisiae chronological lifespan by promoting entry into quiescence”.
See all 3 papers on 4-nitroquinoline 1-oxide
At a glance
The findings reach mice, none yet in people. 2 independent labs in 1 country.
None of its findings points the other way.
- 2 independent labs in 1 country
- Funders: National Institutes of Health and others
- Cells1
What did studies of 4-nitroquinoline 1-oxide find?
2Studies of 4-nitroquinoline 1-oxide measured 2 outcomes: OSM and chronological lifespan.
OSM
upin human cells1upin mice1
1 study
OSM
upin human cells1upin mice1
4-nitroquinoline 1-oxide increases OSM in human cells.
Cellsesophagus100 μg/ml media
4-nitroquinoline 1-oxide increases OSM in 4-NQO-treated esophagus.
Animalsin 4-NQO-treated esophagusesophagus
Chronological lifespan
upin yeast cells1
1 study
Chronological lifespan
upin yeast cells1
4-nitroquinoline 1-oxide extends chronological lifespan in yeast cells (exposure during growth, but not during stationary phase).
Cellsexposure during growth, but not during stationary phaselow doses